<DOC>
	<DOCNO>NCT03093844</DOCNO>
	<brief_summary>This study evaluate safety efficacy Miltenyi CliniMACS® CD34 Reagent System promote engraftment haploidentical CD34+ select cell combine single unit umbilical cord blood transplant treatment high-risk hematologic disorder .</brief_summary>
	<brief_title>Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant Treatment High-risk Hematologic Disorders</brief_title>
	<detailed_description>In clinical protocol , CliniMACS® CD34 Reagent System use process hematopoietic progenitor cell collect apheresis ( HPC , Apheresis ) allogeneic , HLA-haploidentical , related donor obtain CD34+ cell-enriched population hematopoietic reconstitution . The haploidentical donor mobilize G-CSF undergo one apheresis collect CD34+ stem cell . The product cryopreserved time transplantation . Recipients hematologic disorder require transplant receive standard condition regimen receive allograft day 0 contain donor CD34+ cell positively select T-cell deplete follow G-CSF mobilization combine single UCB unit .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<criteria>Recipient Eligibility Ages 1880 year inclusive Diagnosed high risk hematologic disorder warrant stem cell transplant pert institutional standard care Lack HLAidentical relate donor Availability least one HLA haploidentical ( i.e . great equal 5/10 less equal 8/10 HLA match ) relate donor ( HLAA , B , C , DR , DQ locus ) available donate CD34+ cell . Availability least one 4/6 HLAmatched ( HLAA , B , DR locus ) cord blood unit National Marrow Donor Program ( NMDP ) . The cord blood unit must contain minimum TNC ( prior thaw ) least 2x107 cell per kilogram recipient body weight Ability comprehend nature treatment HLA identical ( 6/6 ) relate donor available readily accessible time transplantation evaluation Any patient meeting institutional standard guideline transplant eligibility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Stem Cell Transplant</keyword>
	<keyword>Umbilical Cord Blood Transplant</keyword>
	<keyword>Haploidentical CD34+ Selected Cells</keyword>
</DOC>